河化股份控股股东筹划控制权变更，股票明起停牌，今日涨停

Group 1 - The company received a notification from its controlling shareholder, Ningbo Yinyi Holdings Co., Ltd., regarding the planning of a share transfer, which may lead to a change in the controlling shareholder and actual controller of the company [1] - The company's stock reached a limit up on July 30, closing at 8.02 yuan per share, prior to the announcement [1] - The stock will be suspended from trading starting July 31, with an expected suspension period of no more than two trading days [1] Group 2 - The control change is currently in the negotiation stage, and the outcome remains uncertain as no formal transaction agreements have been signed [1] - The company primarily engages in the research, production, and sales of pharmaceutical intermediates, as well as the commissioned processing and sales of urea [1] Group 3 - In 2024, the company achieved total operating revenue of approximately 212 million yuan, representing a year-on-year increase of 12.81% [1] - The net profit attributable to shareholders of the listed company for 2024 was approximately 79.25 million yuan, showing a significant year-on-year increase of 785.62% [1] - In the first quarter of 2025, the company reported operating revenue of 40.83 million yuan, a year-on-year decrease of 34.05%, while the net profit attributable to shareholders was approximately 1.36 million yuan, reflecting a year-on-year increase of 217.42% [1]